Cereno Scientific adds Project Director to strengthen business capabilities
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that Megha Ranjan has joined the company as Project Director. She will be part of the company’s business and operational team and report to Sten R. Sörensen, Chief Executive Officer (CEO).“I am thrilled to welcome Megha to the team at this pivotal point in the company’s growth journey. Megha has been part of our team in a consultancy capacity during the last two years and will in her new role as Project Director continue to work closely with